AGP Executive Report
Last update: 6 hours agoCBD & Medical Trials: An Australian-made CBD tablet was tested in a 155-person chronic pain trial and was safe, but didn’t beat placebo overall—about 10% reported some pain relief, with researchers noting participants could also use simple pain meds. Public Health Warnings: Hong Kong’s health authority is investigating a probable botulism case after botulinum toxin injections, urging injections only by registered doctors after a patient reported being treated by someone she couldn’t confirm. Cannabis Enforcement: Hong Kong Customs seized ~5kg of suspected cannabis buds from a 20-year-old passenger and arrested him; in the UK, a cannabis dealer was jailed after officers found nearly £5,000 worth of cannabis. Safety for Kids: A Canadian physician warns accidental pediatric cannabis poisonings are rising, driven by edible products that look like regular candy. Industry & Trade: Canada’s cannabis sector is pushing the government to use export growth to diversify trade beyond the U.S., warning rivals may take market share without support. Medical Alternatives & Research: A new study flags kratom products (including 7-OH) as driving a surge in addiction-clinic cases, as regulators consider tighter controls.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
